Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed consolidated statement of cash flows

v3.22.0.1
Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed consolidated statement of cash flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
As Previously Reported [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Net loss $ (20,283) $ (132,878)
Change in fair value of warrants (6,551) 42,239
Change in fair value of subordinated convertible notes   49,561
Issuance of common stock related to convertible debt   100,311
Issuance of common stock related to warrants exercised   73,456
Adjustment [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Net loss (4,362) (4,362)
Change in fair value of warrants 12,046 12,046
Change in fair value of subordinated convertible notes   (7,684)
Issuance of common stock related to convertible debt   (7,684)
Issuance of common stock related to warrants exercised   12,046
As Restated [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Net loss (24,645) (137,240)
Change in fair value of warrants $ 5,495 54,285
Change in fair value of subordinated convertible notes   41,877
Issuance of common stock related to convertible debt   92,627
Issuance of common stock related to warrants exercised   $ 85,502